A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions.

Saved in:
Bibliographic Details
Title: A Trypanosoma cruzi trans-sialidase peptide demonstrates high serological prevalence among infected populations across endemic regions.
Authors: Kortbawi HM; Department of Biochemistry and Biophysics.; Medical Scientist Training Program., Marczak RJ; Department of Epidemiology and Biostatistics, and.; Department of Laboratory Medicine, UCSF, San Francisco, California, USA., Rajan JV; Department of Biochemistry and Biophysics., Bulaong NL; Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA., Pak JE; Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA., Wu W; Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA., Wang G; Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA., Mitchell A; Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA., Saxena A; Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA., Maheshwari A; Department of Epidemiology and Biostatistics, and.; Department of Laboratory Medicine, UCSF, San Francisco, California, USA., Leone RA; Department of Laboratory Medicine, UCSF, San Francisco, California, USA., Fleischmann CJ; Department of Laboratory Medicine, UCSF, San Francisco, California, USA., Kelly EA; Department of Laboratory Medicine, UCSF, San Francisco, California, USA., Teal E; Department of Laboratory Medicine, UCSF, San Francisco, California, USA., Townsend RL; Scientific Affairs, American Red Cross, Gaithersburg, Maryland, USA., Stramer SL; Scientific Affairs, American Red Cross, Gaithersburg, Maryland, USA., Okamoto EE; New York University School of Medicine, New York, New York, USA., Sherbuk JE; New York University School of Medicine, New York, New York, USA., Clark EH; Section of Infectious Diseases, Department of Medicine and.; Division of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Gilman RH; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA., Colanzi RP; Universidad Catolica Boliviana, Santa Cruz, Bolivia., Gennatas ED; Department of Epidemiology and Biostatistics, and.; Department of Medicine, UCSF, San Francisco, California, USA., Bern C; Department of Epidemiology and Biostatistics, and., DeRisi JL; Department of Biochemistry and Biophysics.; Chan Zuckerberg Biohub San Francisco, San Francisco, California, USA., Whitman JD; Department of Laboratory Medicine, UCSF, San Francisco, California, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2026 Feb 05; Vol. 136 (6). Date of Electronic Publication: 2026 Feb 05 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI199277